back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-05-01 13:27 Tx date 2023-04-27 |
$VPH
VALEO PHARMA INC. |
Fowler, Stuart William
4 - Director of Issuer
Direct Ownership
|
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-08-11 23:14 Tx date 2020-08-06 |
$AQS
Aequus Pharmaceuticals Inc. |
Fowler, Stuart William
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+312,500 vol |
312,500 | |
| Filed 2020-08-11 23:11 Tx date 2020-02-01 |
$AQS
Aequus Pharmaceuticals Inc. |
Fowler, Stuart William
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-08-11 23:11 Tx date 2020-08-06 |
$AQS
Aequus Pharmaceuticals Inc. |
Fowler, Stuart William
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$50,000
+625,000 vol $0.08 each |
625,000 | |
| Filed 2020-08-11 23:09 Tx date 2020-02-01 |
$AQS
Aequus Pharmaceuticals Inc. |
Fowler, Stuart William
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-08-11 23:08 Tx date 2020-02-14 |
$AQS
Aequus Pharmaceuticals Inc. |
Fowler, Stuart William
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+350,000 vol |
350,000 | |
| Filed 2020-08-11 23:06 Tx date 2020-02-01 |
$AQS
Aequus Pharmaceuticals Inc. |
Fowler, Stuart William
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|